Uploaded on Jan 18, 2024
According to the latest research report by IMARC Group, The global pet oral care products market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.68% during 2024-2032. More Info:- https://www.imarcgroup.com/pet-oral-care-products-market
Pet Oral Care Products Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
Global Pet Oral Care Products Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . Acco r d ing t o t he l a t e s t r epo r t by I M ARC G r oup , t i t l ed "P et O ra l Care Produ ct s M ar ke t : G l ob a l I ndu st ry T rend s , Shar e , S i ze , G row t h , O pp or t u n i t y and Fo rec as t 2024 - 203 2 , " t he g lob a l pe t o r a l ca r e p r odu c t s m ar ke t s i ze r ea ched U S$ 2 . 0 B i l l i on i n 2 023 . Pe t o r a l c a r e p r o duc t s r e f e r t o a r ange o f spec ia l i zed i t em s des ig ned t o m a in t a in Report and im pr ov e t he den t a l hea l t h o f do m es t i c an im a ls , p a r t i cu la r l y dog s , and ca t s . Thes e p r od uc t s a r e t a i l o r ed t o add r ess o r a l i s s ues , suc h as p laque , t a r t a r , b ad Highlight and b r ea t h , a nd g um d i sease t ha t ca n im pac t pe t s ' o ve r a l l we l l - b e ing . Pe t o r a l c a r e p r oduc t s i nc lude t oo t h b r us hes , t oo t hpa s t e , de n t a l ch ews , r i ns es , a nd ge l s , a l l f o r m u la t ed w i t h pe t - f r i end l y i n g r ed i en t s t ha t a id i n p r eve n t i n g de n t a l Description a i lm e n t s . Th e r egu la r use o f t he se p r o duc t s c an he lp r em ove f oo d p a r t i c l e s , bac t e r i a , an d deb r i s f r om a p e t ' s t ee t h an d gum s , t he r e by r educ i ng t he r i s k o f o r a l hea l t h p r ob lem s . T he m a in f ocus o f pe t o r a l ca r e p r od uc t s i s t o en hance pe t s ' qua l i t y o f l i f e a nd r educ e t he r i s k o f d en t a l - r e la t ed c om p l i c a t i on s . Reque st f o r a P DF s ampl e o f t h i s repor t : h t t p s : / / www. im ar c g r ou p . com / pe t - o r a l - ca r e - p r od uc t s - m a r ke t / r equ es t sa m p le Report Description G l o b a l P e t O r a l C a r e P r o d u c t s M a r k e t T r e n d s : T h e i n c r e a s i n g a w a r e n e s s a m o n g p e t o w n e r s r e g a r d i n g t h e s i g n i f i c a n c e o f o r a l h y g i e n e a n d i t s i m p o r t a n c e i n m a i n t a i n i n g t h e o v e r a l l h e a l t h a n d c o m f o r t o f p e t s i s o n e o f t h e m a j o r f a c t o r s c o n t r i b u t i n g t o t h e m a r k e t g r o w t h . A d d i t i o n a l l y , t h e i n t r o d u c t i o n o f n o v e l f o r m u l a t i o n s b y m a n u f a c t u r e r s e n r i c h e d w i t h n a t u r a l a n d s a f e i n g r e d i e n t s , c a t e r i n g t o t h e r i s i n g d e m a n d f o r s u s t a i n a b l e p e t c a r e s o l u t i o n s , i s c r e a t i n g a p o s i t i v e o u t l o o k f o r t h e m a r k e t g r o w t h . M o r e o v e r , t h e g r o w i n g p r e f e r e n c e f o r c o n v e n i e n c e a m o n g p e t o w n e r s l e a d i n g t o t h e d e v e l o p m e n t o f e a s y - t o - u s e o r a l c a r e p r o d u c t s , s u c h a s d e n t a l c h e w s t h a t s i m u l t a n e o u s l y s e r v e a s t r e a t s , i s f a v o r i n g t h e m a r k e t g r o w t h . I n a d d i t i o n t o t h i s , t h e i n c r e a s i n g c o l l a b o r a t i o n b e t w e e n p e t c a r e b r a n d s a n d v e t e r i n a r y p r o f e s s i o n a l s t o e n h a n c e t h e c r e d i b i l i t y o f p r o d u c t s a n d e n c o u r a g e s p e t o w n e r s t o i n v e s t i n p r e m i u m a n d s p e c i a l i z e d o f f e r i n g s i s p r o v i d i n g a t h r u s t t o t h e m a r k e t g r o w t h . F u r t h e r m o r e , t h e r i s i n g d e n t a l i s s u e s i n p e t s , i n c l u d i n g p l a q u e b u i l d u p , g u m d i s e a s e , a n d b a d b r e a t h , a f f e c t i n g p e t s ' c o m f o r t a n d o v e r a l l h e a l t h , e n c o u r a g i n g p e t o w n e r s t o s e e k w a y s t o a d d r e s s t h e m , i s p r o v i d i n g a n i m p e t u s t o t h e m a r k e t g r o w t h . O t h e r f a c t o r s , i n c l u d i n g t h e i n c r e a s i n g d i s p o s a b l e i n c o m e o f p e t o w n e r s , l i f e s t y l e c h a n g e s , g r o w i n g a g i n g p e t p o p u l a t i o n , r i s i n g s p e n d i n g p o w e r o n p e t h e a l t h c a r e , a n d e d u c a t i o n i n i t i a t i v e s a b o u t p e t h e a l t h a n d w e l l n e s s , a r e p r o v i d i n g r e m u n e r a t i v e g r o w t h o p p o r t u n i t i e s f o r t h e m a r k e t . L o o k i n g f o r w a r d , t h e m a r k e t v a l u e i s p r o j e c t e d t o r e a c h U S $ 3 . 4 B i l l i o n b y 2 0 3 2 , e x p a n d i n g a t a C A G R o f 5 . 6 8 % d u r i n g 2 0 2 4 - 2 0 3 2 . V i e w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / p e t - o r a l - c a r e - p r o d u c t s - m a r k e t Product Type Insights: • Toothbrush • Toothpaste • Mouthwash/Rinse • Dental Chews • Others Report Animal Type Insights: Segmentation • Dogs • Cats • Others Distribution Channel Insights: • Supermarkets and Hypermarkets • Online Stores • Special ized Pet Shops • Veterinary Channels • Others Regional Insights: • North America Report • Asia-Pacifi c Segmentation • Europe • Latin America • Middle East and Afr ica • Al l4pets • Al lAccem Inc. • Ceva Santé Animale • Cosmos Corporat ion Competitive • Dechra Pharmaceuticals plc Landscape • Goran Pharma Pvt. Ltd. • Hi l l 's Pet Nutr i t ion Inc. (Colgate-Palmol ive with Key Company) Players • Imrex Inc. • Nestlé Purina PetCare Company (Nest lé S.A.) • Petz l i fe UK • Vetoquinol SA • Virbac How has the global pet oral care products market performed so far and how will it perform in the coming years? What are the drivers, restraints, and opportunities in the global pet oral care products market? What are the key regional markets? Key Which countries represent the most attractive pet oral Questions care products markets? Answered in What is the breakup of the market based on the product type? the Report What is the breakup of the market based on the animal type? What is the breakup of the market based on the distribution channel? What is the competitive structure of the global pet oral care products market? Who are the key players/companies in the global pet oral care products market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l P e t O r a l C a r e P r o d u c t s M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y P r o d u c t T y p e 6 . 1 T o o t h b r u s h 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 T o o t h p a s t e 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 M o u t h w a s h / R i n s e 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 D e n ta l C h e w s 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t 6 . 5 O t h e r s 6 . 5 . 1 M a r k e t T r e n d s 6 . 5 . 2 M a r k e t F o r e c a s t 7 M a r k e t B r e a k u p b y A n i m a l T y p e 7 . 1 D o g s 7 . 1 . 1 M a r k e t T r e n d s Table of 7 . 1 . 2 M a r k e t F o r e c a s t 7 . 2 C a t s 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 M a r k e t F o r e c a s t Contents 7 . 3 O t h e r s 7 . 3 . 1 M a r k e t T r e n d s 7 . 3 . 2 M a r k e t F o r e c a s t 8 M a r k e t B r e a k u p b y D is t r ib u t io n C h a n n e l 8 . 1 S u p e r m a r k e t s a n d H y p e r m a r k e t s 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t 8 . 2 O n l i n e S to r e s 8 . 2 . 1 M a r k e t T r e n d s 8 . 2 . 2 M a r k e t F o r e c a s t 8 . 3 S p e c i a l i z e d P e t S h o p s 8 . 3 . 1 M a r k e t T r e n d s 8 . 3 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t io n , v i s i t : ht tps : / /www. imarcgroup .com/pe t - o ra l - ca re -p roduct s -market / toc Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]
Comments